C1-Inhibitor: Structure, Functional Diversity And Therapeutic ...

Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

Human C1-Inhibitor (C1INH), also known as C1-esterase inhibitor, is an important multifunctional plasma glycoprotein that is uniquely involved in a regulatory network of complement, contact, coagulation, and fibrinolytic systems. C1INH belongs to a superfamily of serine proteinase inhibitors (serpins) and exhibits its inhibitory activities towards several target proteases of plasmatic cascades, operating as a major antiinflammatory protein in the circulation. In addition to its inhibitory activities, C1INH is also involved in non-inhibitory interactions with some endogenous proteins, polyanions, cells and infectious agents. While C1INH is essential for multiple physiological processes, it is better known for its deficiency with regards to Hereditary Angioedema (HAE), a rare autosomal dominant disease clinically manifested by recurrent acute attacks of increased vascular permeability and edema. Since the link was first established between functional C1INH deficiency in plasma and HAE in the 1960s, tremendous progress has been made in the biochemical characterization of C1INH and its therapeutic development for replacement therapies in patients with C1INH-dependent HAE. Various C1INH biological activities, recent advances in the HAE-targeted therapies, and availability of C1INH commercial products have prompted intensive investigation of the C1INH potential for the treatment of clinical conditions other than HAE. This article provides an updated overview of the structural and biological activities of C1INH, its role in HAE pathogenesis, and recent advances in the research and therapeutic development of C1INH; it also considers some trends for using C1INH therapeutic preparations for applications other than angioedema, from sepsis and endotoxin shock to severe thrombotic complications in COVID-19 patients.

Keywords: C1-inhibitor; C1-inhibitor products; complement; contact system; hereditary angioedema; therapeutic development..

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

PubMed Disclaimer

Similar articles

• sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor. Larrauri B, Hester CG, Jiang H, Miletic VD, Malbran A, Bork K, Kaplan A, Frank M. Larrauri B, et al. Mol Immunol. 2020 Mar;119:27-34. doi: 10.1016/j.molimm.2020.01.003. Epub 2020 Jan 16. Mol Immunol. 2020. PMID: 31955064
• COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications. Veronez CL, Christiansen SC, Smith TD, Riedl MA, Zuraw BL. Veronez CL, et al. Allergy Asthma Proc. 2021 Nov 1;42(6):506-514. doi: 10.2500/aap.2021.42.210083. Allergy Asthma Proc. 2021. PMID: 34871158 Free PMC article.
• Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade. Busse P, Kaplan A. Busse P, et al. J Allergy Clin Immunol Pract. 2022 Mar;10(3):716-722. doi: 10.1016/j.jaip.2021.11.011. Epub 2021 Nov 25. J Allergy Clin Immunol Pract. 2022. PMID: 34838707
• Contact System Activation and Bradykinin Generation in Angioedema: Laboratory Assessment and Biomarker Utilization. Christiansen SC, Zuraw BL. Christiansen SC, et al. Immunol Allergy Clin North Am. 2024 Aug;44(3):543-560. doi: 10.1016/j.iac.2024.03.011. Epub 2024 May 18. Immunol Allergy Clin North Am. 2024. PMID: 38937015 Review.
• Preventive Treatment of Hereditary Angioedema: A Review of Phase III Clinical Trial Data for Subcutaneous C1 Inhibitor and Relevance for Patient Management. West JB, Poarch K, Lumry WR. West JB, et al. Clin Ther. 2021 Dec;43(12):2154-2166.e1. doi: 10.1016/j.clinthera.2021.10.008. Epub 2021 Dec 5. Clin Ther. 2021. PMID: 34879971 Review.

See all similar articles

Cited by

• The Crystal Structure of the Michaelis-Menten Complex of C1 Esterase Inhibitor and C1s Reveals Novel Insights into Complement Regulation. Garrigues RJ, Garrison MP, Garcia BL. Garrigues RJ, et al. J Immunol. 2024 Sep 1;213(5):718-729. doi: 10.4049/jimmunol.2400194. J Immunol. 2024. PMID: 38995166
• Viral anti-inflammatory serpin reduces immuno-coagulopathic pathology in SARS-CoV-2 mouse models of infection. Zhang L, Li YH, Kibler K, Kraberger S, Varsani A, Turk J, Elmadbouly N, Aliskevich E, Spaccarelli L, Estifanos B, Enow J, Zanetti IR, Saldevar N, Lim E, Schlievert J, Browder K, Wilson A, Juan FA, Pinteric A, Garg A, Monder H, Saju R, Gisriel S, Jacobs B, Karr TL, Florsheim EB, Kumar V, Wallen J, Rahman M, McFadden G, Hogue BG, Lucas AR. Zhang L, et al. EMBO Mol Med. 2023 Sep 11;15(9):e17376. doi: 10.15252/emmm.202317376. Epub 2023 Aug 3. EMBO Mol Med. 2023. PMID: 37534622 Free PMC article.
• Mechanisms involved in hereditary angioedema with normal C1-inhibitor activity. Shamanaev A, Dickeson SK, Ivanov I, Litvak M, Sun MF, Kumar S, Cheng Q, Srivastava P, He TZ, Gailani D. Shamanaev A, et al. Front Physiol. 2023 May 23;14:1146834. doi: 10.3389/fphys.2023.1146834. eCollection 2023. Front Physiol. 2023. PMID: 37288434 Free PMC article. Review.
• Factor XII Structure-Function Relationships. Shamanaev A, Litvak M, Ivanov I, Srivastava P, Sun MF, Dickeson SK, Kumar S, He TZ, Gailani D. Shamanaev A, et al. Semin Thromb Hemost. 2024 Oct;50(7):937-952. doi: 10.1055/s-0043-1769509. Epub 2023 Jun 5. Semin Thromb Hemost. 2024. PMID: 37276883 Review.
• The impact of puberty on the onset, frequency, location, and severity of attacks in hereditary angioedema due to C1-inhibitor deficiency: A survey from the Italian Network for Hereditary and Acquired Angioedema (ITACA). Cancian M, Triggianese P, Modica S, Arcoleo F, Bignardi D, Brussino L, Colangelo C, Di Agosta E, Firinu D, Guarino MD, Giardino F, Giliberti M, Montinaro V, Senter R. Cancian M, et al. Front Pediatr. 2023 Apr 18;11:1141073. doi: 10.3389/fped.2023.1141073. eCollection 2023. Front Pediatr. 2023. PMID: 37144145 Free PMC article.

See all "Cited by" articles

Publication types

• Review Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

MeSH terms

• Angioedemas, Hereditary* / drug therapy Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• COVID-19 Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Complement C1 Inhibitor Protein* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Humans Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Substances

• Complement C1 Inhibitor Protein Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Related information

• Gene
• Gene (GeneRIF)
• MedGen
• Protein (RefSeq)

LinkOut - more resources

• Full Text Sources

  • Bentham Science Publishers Ltd.
  • Ingenta plc